Proton Pump Inhibitors Are Associated with Increased Risk of Psoriasis: A Nationwide Nested Case-Control Study
Conclusions: PPI use might be associated with an increased risk of developing psoriasis or as an epiphenomenon. Further prospective studies are needed to elucidate the association and underlying mechanisms.Dermatology
Source: Dermatology - Category: Dermatology Source Type: research
More News: Databases & Libraries | Dermatology | Health Insurance | Insurance | Lansoprazole | Prevacid | Proton Pump Inhibitors PPIs | Psoriasis | Skin | Study | Taiwan Health